29 Aug 2014
Intratympanic glucocorticoids are effective in the treatment of sudden sensorineural hearing loss, the stabilization of Ménière's disease, and in autoimmune ear disorders. Intratympanic administration should minimise systemic side effects. Novoa and colleagues carried out a prospective cohort study, finding that intratympanic dexamethason did not interfere with endogenous cortisol secretion or bone metabolism.
Read the full article at Novoa et al. (2014) Endocrine Connections 3 127–131; DOI:10.1530/EC-14-0076
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024